adoptive immunotherapy

(redirected from adoptive transfer)
Also found in: Medical, Encyclopedia.
Related to adoptive transfer: Flow cytometry, transgenic

adoptive immunotherapy

n.
A form of immunotherapy used in the treatment of cancer and certain viral infections in which lymphocytes taken from a patient are stimulated, activated, and infused back into the patient.
References in periodicals archive ?
Using innovate combinations of genetics and adoptive transfer protocols we will test whether this knowledge can be employed to reverse macrophage dependent loss of immune competence and failed tissue regeneration with age.
Studies conducted by the National Cancer Institute of adoptive transfer of in vitro-selected tumor-infiltrating lymphocytes were the first to demonstrate the potential of T-cell immunotherapy to eradicate solid tumors.
Infusion of UVB-iDCs to Allogeneic Recipients Induces Long-Lasting Alloantigen-Specific Tolerance, Which Is Transferable through Adoptive Transfer of CD4+ T Cells.
We used data from individual animals in all experiments; however, for adoptive transfer experiments, data were concatenated due to the low number of gated events for T-cell subsets.
Within these cell populations, they then identified subgroups and proceeded with a series of single-cell adoptive transfer experiments, in which the aftermath of immune responses could be analyzed in detail.
He pointed out that different specific-immunotherapeutic modalities, including cancer vaccines and adoptive transfer had been developed and examined in different phases of clinical trials.
Recent preclinical and clinical studies provide evidence that adoptive transfer of in vitro activated T cells can results in significant antitumour responses in vivo upon acquisition of certain survival and homing properties during in vitro activation.
host (GvH) disease and graft rejection; cell therapy to prevent leukemia relapse; modalities to improve immune reconstitution after transplantation; clinical studies on boosting thymus output or using adoptive transfer of immunity against infectious agents or malignant cells; and new approaches to induce immune tolerance towards organ transplantation by hematopoietic stem cell transplantation.
In vitro studies and in vivo adoptive transfer experiments revealed that CD4+CD25+ T cells from GM-CSFtreated mice could suppress effector T cell response and T1D.
Consequently, it has become possible to create immune recognition of cancer antigens through immunization and through adoptive transfer of antitumor lymphocytes into a lymphodepleted host.
We conclude that accumulation is most likely due to pro longed cell survival, because adoptive transfer experiments demonstrated that C-Med 100 [R] treatment significantly prolonged lymphocyte survival in peripheral lymphoid organs, without increasing their proliferation rate.